sponsored byAAAS Golden Fund

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 51-75 out of 1337.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 > >>

Public Release: 4-Apr-2017
KU Leuven to lead development of dual vaccine against yellow fever and rabies
Rabies and yellow fever claim ten thousands of lives each year. Vaccines already exist but various drawbacks that hinder their efficient distribution. One of them is the need to transport and store these vaccines at cool temperatures. The RABYD-VAX consortium, led by KU Leuven (University of Leuven, Belgium), has now started developing a cheap, temperature-stable, and easy-to-produce vaccine against both diseases at once.
European Union's Horizon 2020 Research and Innovation Programme

Contact: Johan Neyts
johan.neyts@kuleuven.be
32-163-21893
KU Leuven

Public Release: 4-Apr-2017
mBio
MERS-like coronavirus identified in Ugandan bat
A team of researchers in the United States and Uganda has identified a novel coronavirus in a bat from Uganda that is similar to the one causing Middle East Respiratory Syndrome (MERS) in people, giving further credence to the theory that such viruses originate in bats. The work was described this week in mBio®, an online open-access journal of the American Society for Microbiology.
United States Agency for International Development Emerging Pandemic Threats PREDICT project, NIH/National Institutes of Allergy and Infectious Disease, NIH/National Institute of Diabetes and Digestive and Kidney Diseases

Contact: Tim Paul
tp2111@columbia.edu
212-305-2676
Columbia University's Mailman School of Public Health

Public Release: 31-Mar-2017
University of Miami to begin phase 2 Zika vaccine trial
The University of Miami Miller School of Medicine will soon begin one of the nation's first full-scale Zika vaccine clinical trials testing the National Institutes of Health's (NIH) experimental DNA-based vaccine. As Miami-Dade County has been ground zero for the Zika virus outbreak in the U.S., testing the vaccine in an endemic region is critical to help determine the vaccine's safety, effective dosage and whether it can effectively prevent disease caused by Zika infection.
NIH/National Institute of Allergy and Infectious

Contact: Kai Hill
khill@miami.edu
305-243-3249
University of Miami

Public Release: 31-Mar-2017
European Journal of Preventive Cardiology
Insomnia associated with increased risk of heart attack and stroke
Insomnia is associated with increased risk of heart attack and stroke, according to research published today in the European Journal of Preventive Cardiology.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 30-Mar-2017
Annals of Neurology
The US burden of neurological disease is nearly $800 billion/year
The most common neurological diseases cost the United States $789 billion in 2014, and this figure is projected to grow as the elderly population doubles between 2011 and 2050, according to a new study published in the April issue of the Annals of Neurology.

Contact: Dawn Peters & Tracy Simon
tsimon@steegethomson.com
781-388-8408
Wiley

Public Release: 29-Mar-2017
Vaccine
Global immunization impact constrained by outdated vaccine delivery systems, researchers say
Outdated vaccine supply and distribution systems are delaying and limiting the impact that vaccines have on safeguarding people's health. Among the challenges of ensuring a consistent supply of potent vaccines identified by researchers: one in every three countries in the world experiences at least one stockout of at least one vaccine for at least one month; and 19 to 38 percent of vaccines worldwide are accidentally exposed to freezing temperatures, potentially compromising the potency of those vaccines.

Contact: Preeti Singh
psingh@burness.com
301-280-5722
Burness

Public Release: 28-Mar-2017
PLOS Neglected Tropical Diseases
Wealth and knowledge drive bushmeat consumption during the West African Ebola crisis
Bushmeat, or wild animal meat, is an essential source of protein for many people in tropical regions. But handling and eating bushmeat carries the risk of contracting diseases, such as Ebola virus disease (EVD). During the latest and largest ever recorded Ebola crisis, household income and specific knowledge about the risks of eating bushmeat were linked to changes in its consumption, researchers report in PLOS Neglected Tropical Diseases. Although bushmeat consumption in Liberia generally decreased during the crisis, preferences for bushmeat remained constant.

Contact: PLOS Neglected Tropical Diseases
plosntds@plos.org
PLOS

Public Release: 28-Mar-2017
Population and Environment
Study finds that elevating women's status lowers dependence on solid fuels
A new research paper finds that in countries where gender inequalities are most pronounced, women are much more likely to be exposed to solid fuel -- including burning from wood, crop wastes, charcoal, and dung -- and its negative consequences.

Contact: Lauren Stralo
lkw214@lehigh.edu
267-377-7671
Lehigh University

Public Release: 28-Mar-2017
eLife
'Flying syringes' could detect emerging infectious diseases
Blood-sucking flies can act as 'flying syringes' to detect emerging infectious diseases in wild animals before they spread to humans, according to research published in the journal eLife.
Agence Universitaire de la Francophonie (AUF), Service de Coopération et d'Action Culturelle de l'ambassade de France au Gabon, LMI ZOFAC IRD, CIRMF, ANR JCJC 07-2012-ORIGIN

Contact: Emily Packer
e.packer@elifesciences.org
01-223-855-373
eLife

Public Release: 28-Mar-2017
Molecular Biology and Evolution
Herpes STDs: From chimps to humans to cold sore cousin mixing before worldwide spread
Evolutionarily, Herpes simplex virus 1 and 2 are considered cousins, and are thought to have evolved independently, Now, an entirely new picture is emerging. While scientists did not find evidence of chimpanzee herpes virus fragments in HSV-2 genomes, they show the history of HSV-2 was marked by recombination with HSV-1. In addition, they determined two main lineages of HSV-2, one globally distributed and another restricted to sub-Saharan Africa, which both started diversifying about 30,000 years ago.

Contact: Joseph Caspermeyer
MBEpress@gmail.com
480-258-8972
Molecular Biology and Evolution (Oxford University Press)

Public Release: 27-Mar-2017
Nature Communications
Zika virus protein mapped to speed search for cure
A study published today reports that a team led by Indiana University scientists has mapped a key protein that causes the Zika virus to reproduce and spread.
NIH/National Institute of General Medical Sciences, Howard Hughes Medical Institute, US Department of Energy

Contact: Kevin Fryling
kfryling@iu.edu
812-856-2988
Indiana University

Public Release: 27-Mar-2017
Journal of General Internal Medicine
A little nudge may provide a big boost to flu vaccination rates
Currently, only 44 percent of adults in the United States receive an annual flu vaccination. But, a new study suggests that a simple behavioral economics technique may be able to help. In the study, researchers programmed electronic health records (EHR) to alert care providers when a patient was eligible, and prompt them to choose to 'accept' or 'decline' a flu vaccination order. Results showed a 37 percent relative increase in vaccinations from the prior year.

Contact: Katie Delach
katie.delach@uphs.upenn.edu
215-349-5964
University of Pennsylvania School of Medicine

Public Release: 27-Mar-2017
Nature Communications
Researchers crack structure of key protein in Zika virus
The genomic replication of the Zika virus (ZIKV) is made possible by its 'NS5' protein. UC Riverside scientists report that they have determined the crystal structure of the entire ZIKV NS5 protein and demonstrated that NS5 is functional when purified in vitro. Knowing the structure of ZIKV NS5 helps the researchers understand how ZIKV replicates itself. Further, the researchers identified the inhibitor-binding site of NS5, enabling scientists to design potential potent drugs to fight ZIKV.
March of Dimes Foundation, Sidney Kimmel Foundation for Cancer Research, National Institutes of Health

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside

Public Release: 27-Mar-2017
Proceedings of the National Academy of Sciences
A new test to rapidly identify worldwide TB infections
A group of scientists from Arizona, Texas and Washington, D.C., has teamed up to develop the first rapid blood test to diagnose and quantify the severity of active TB cases. Led by Tony Hu, a researcher at Arizona State University's Biodesign Institute, eight research groups, including the Houston Methodist Research Institute and scientists at the National Institutes of Health, are harnessing the new field of nanomedicine to improve worldwide TB control.

Contact: Joe Caspermeyer
joseph.caspermeyer@asu.edu
480-727-0369
Arizona State University

Public Release: 24-Mar-2017
Future Science OA
New lab-on-a-chip platform seeks to improve pathogen detection
Researchers from the Fraunhofer Institute have developed a new prototype lab-on-a-chip platform for the easy and versatile detection of molecular pathogens.

Contact: Leela Ripton
l.ripton@future-science-group.com
Future Science Group

Public Release: 23-Mar-2017
Science
Scientists assemble Zika virus mosquito genome from scratch
A team of scientists has developed a new way to sequence genomes, which can assemble the genome of an organism, entirely from scratch, dramatically cheaper and faster.

Contact: Graciela Gutierrez
ggutierr@bcm.edu
713-798-4710
Baylor College of Medicine

Public Release: 23-Mar-2017
Journal of Interferon & Cytokine Research
New understanding of chronic lung inflammatory diseases unfolding
Researchers studying chronic inflammation that can lead to the development of lung diseases such as asthma, pulmonary fibrosis, and cancer, are focusing on the role cytokines play in regulating the behavior of fibroblast cells and the extracellular matrix.

Contact: Kathryn Ryan
kryan@liebertpub.com
914-740-2250
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 23-Mar-2017
European Heart Journal
Cardiac lead extractions safer in high volume centers
Cardiac lead extraction is safer in high volume centers, according to the largest study of contemporary practice in Europe published today in European Heart Journal. Extraction in a low volume center was associated with a doubled risk of death while in hospital.
Boston Scientific, Cook Medical, Medtronic, Spectranetics and Zoll

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 23-Mar-2017
Science
Most dengue infections transmitted in and around home
Transmission of the mosquito-borne dengue virus appears to be largely driven by infections centered in and around the home, with the majority of cases related to one another occurring in people who live less than 200 meters apart, new research led by the Johns Hopkins Bloomberg School of Public Health and the University of Florida suggests.
NIH/National Institute of Allergy and Infectious Diseases, National Science Foundation, Global Emerging Infections Surveillance and Response System, Armed Services Health Surveillance Health Center

Contact: Stephanie Desmon
sdesmon1@jhu.edu
410-955-7619
Johns Hopkins University Bloomberg School of Public Health

Public Release: 22-Mar-2017
New England Journal of Medicine
New low-cost rotavirus vaccine could reduce disease burden in developing countries
A new vaccine for rotavirus was found to be 66.7 percent effective in preventing severe gastroenteritis caused by the virus, according to a new study from researchers at Harvard T.H. Chan School of Public Health and Epicentre, Paris.
Médecins Sans Frontières, Kavli Foundation

Contact: Todd Datz
tdatz@hsph.harvard.edu
617-432-8413
Harvard T.H. Chan School of Public Health

Public Release: 21-Mar-2017
Sussex Drug Discovery Centre & ReViral reach clinical trial with lung virus treatment
Sussex Drug Discovery Centre & ReViral reached a clinical trial with a 'game changer' treatment for respiratory syncytial virus.

Contact: Lynsey Ford
lynsey.ford@sussex.ac.uk
01-273-678-888
University of Sussex

Public Release: 21-Mar-2017
PLOS ONE
Interferon drug shows promise in treating Ebola
A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.
Canadian Institutes of Health Research, European Mobile Laboratory

Contact: Alex Radkewycz
Alexandra.Radkewycz@uhn.ca
416-340-3895
University Health Network

Public Release: 21-Mar-2017
Molecular Biology and Evolution
HIV co-infection influences natural selection on M. tuberculosis
While M. tuberculosis has been evolving with humans for thousands of years, HIV co-infections create host immunological environments that this bacterium has not encountered before and could, therefore, be nudging it to evolve new characteristics. Now, an evolutionary analysis of M. tuberculosis full genome sequences from HIV uninfected and HIV co-infected individuals uncovered specific sites within M. tuberculosis genomes where the bacterium may have been compelled to evolve in response to HIV-1 co-infections.

Contact: Joseph Caspermeyer
MBEpress@gmail.com
480-258-8972
Molecular Biology and Evolution (Oxford University Press)

Public Release: 20-Mar-2017
Scientific Reports
Testing for Zika virus: There's an app for that
Add rapid, mobile testing for Zika and other viruses to the list of things that smartphone technology is making possible. Researchers at Sandia National Laboratories have developed a smartphone-controlled, battery-operated diagnostic device that weighs under a pound, costs as little as $100 and can detect Zika, dengue and chikungunya within 30 minutes.

Contact: Jules Bernstein
Jberns@sandia.gov
925-337-3229
DOE/Sandia National Laboratories

Public Release: 20-Mar-2017
Proceedings of the National Academy of Sciences
Vaccine, improved treatment are keys to control of a surging HIV pandemic
Development and widespread use of a vaccine that's even partially effective against HIV, along with more progress toward diagnosis and treatment, offer the best hopes for turning the corner on a global pandemic that's still spiraling out of control, researchers reported today.
National Institutes of Health

Contact: Jan Medlock
jan.medlock@oregonstate.edu
541-737-6874
Oregon State University

Showing releases 51-75 out of 1337.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 > >>